Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ramoplanin

EU orphan designation number: EU/3/01/049   
Active ingredient: Ramoplanin
Indication: Prevention of invasive infections due to Vancomycin Resistant Enterococci (VRE) in colonised patients deemed at risk of infection
Sponsor: Vicuron Pharmaceuticals Italy srl,
v. R. Lepetit, 34, 21040 Gerenzano (VA), Italia

  

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
10/07/2001 Centralised Orphan - Designation EMEA/OD/034/00 (2001)1393 of 09/07/2001